Charlotte's Web Holdings (CWBHF) Cash from Financing Activities (2021 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Cash from Financing Activities of -$41000.0 for Q1 2026, down 156.25% quarter-over-quarter from -$16000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Cash from Financing Activities for 6 consecutive years, with -$41000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to -$41000.0; the TTM figure through Mar 2026 stood at -$91000.0 (down 93.62% YoY), while the FY2025 annual figure was -$50000.0, up 65.52% from the prior year.
- Cash from Financing Activities fell to -$41000.0 in Q1 2026 per CWBHF's latest filing, from -$16000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $52.7 million in Q4 2022 and bottomed at -$265000.0 in Q3 2022.
- Historically, Cash from Financing Activities has averaged $3.2 million across 5 years, with a median of -$22500.0 in 2024.
- On a YoY basis, Cash from Financing Activities climbed as much as 883.65% in 2022 and fell as far as 393.75% in 2022.
- Charlotte's Web Holdings' Cash from Financing Activities stood at $52.7 million in 2022, then tumbled by 100.09% to -$49000.0 in 2023, then jumped by 75.51% to -$12000.0 in 2024, then plunged by 33.33% to -$16000.0 in 2025, then tumbled by 156.25% to -$41000.0 in 2026.
- Business Quant data shows CWBHF's Cash from Financing Activities at -$41000.0 in Q1 2026, -$16000.0 in Q4 2025, and -$9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Charlotte's Web Holdings | 63.58 Mn | 49.59 Mn | 5.16 Mn | 9.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.74 Mn |
| Jun 30, 2026 | 9.74 Mn |
| Mar 31, 2026 | -41,000.00 |
| Mar 31, 2026 | -41,000.00 |
| Dec 31, 2025 | -16,000.00 |
| Dec 31, 2025 | -16,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Dec 31, 2023 | -49,000.00 |